Darzalex 400 mg Daratumumab Injection

Darzalex 400mg Injection – Effective Treatment for Multiple Myeloma

Overview

Darzalex 400 mg Injection primarily comes in use for the treatment of multiple myeloma, a cancer that affects plasma cells. Daratumumab Injection belongs to the class of monoclonal antibodies and works by targeting specific proteins on cancer cells, helping the immune system eliminate them.

Administration and Dosage

This injection is administered as an intravenous (IV) infusion under the strict supervision of a healthcare professional. The dosage and frequency are determined by your doctor based on your medical condition. Adhering to the prescribed dosage is crucial, as incorrect use can lead to severe side effects. While it may take weeks or months to show significant improvements, do not discontinue use without consulting your doctor.

Possible Side Effects

Like all medications, Daratumumab Injection may cause side effects. Some common ones include:

• Infusion reactions: Swelling of the face, lips, mouth, or throat, difficulty breathing, or swallowing
• Blood cell reduction: Increased risk of infections due to a decrease in white blood cells
• Gastrointestinal issues: Nausea, diarrhea, or decreased appetite
• Respiratory infections: Increased susceptibility to colds and flu
• Fatigue and muscle weakness
• Joint inflammation and back pain

If you experience persistent or severe side effects, seek medical attention immediately. Regular blood tests may be necessary to monitor your body’s response to the treatment.

Precautions and Warnings

• Pregnancy and Breastfeeding: Not recommended during pregnancy or while nursing. Effective contraception is advised during treatment.
• Drug Interactions: Inform your healthcare provider about all medications you are taking to prevent harmful interactions.